Tenderwize
Back to tender search

Open House Original Discount Agreements 2025-10 - Umeclidinium Bromide + Vilanterol

Techniker Krankenkasse·Hamburg, Germany·Deadline Apr 29, 2027 · 254 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-10 - Umeclidiniumbromid+Vilanterol

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

No guaranteed minimum volume or estimated value; actual uptake may be low.

Contract terminates automatically upon patent expiry of the drug combination.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Conclusion of discount agreements for the drug combination Umeclidiniumbromid+Vilanterol under §130c SGB V.
  • Open House procedure: uniform conditions, no individual negotiations.
Show full summary

Open House procedure by Techniker Krankenkasse for discount agreements on the drug combination Umeclidiniumbromid+Vilanterol (CPV 33600000). Contract period max 24 months from 01.05.2025 to 30.04.2027. No exclusivity; any eligible pharmaceutical entrepreneur can join at any time.

Risks

No guaranteed minimum volume or estimated value; actual uptake may be low.

Contract terminates automatically upon patent expiry of the drug combination.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as defined in §4 Abs. 18 AMG.
  • Must have valid marketing authorization for the specific drug combination.

Eligibility

  • Must submit declaration of eligibility (Anlage 4) with signed documents.

Requirements may be incomplete.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Original Discount Agreements 2025-10 - Umeclidinium Bromide + Vilanterol

Discount agreement for the drug combination Umeclidinium bromide + Vilanterol.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Apr 2025 - Apr 2027

Category

Pharmaceutical products

Deadline

Deadline Apr 29, 2027

Procurement Details

Publication date
27 Mar 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
201823-2025

Documents (1)

Similar tenders